Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Creatine Safety & Tolerability Extension in Premanifest HD
NCT01411150Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- May 2009
- Primary completion
- Sep 2012
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of creatine in Huntington's disease (HD), sponsored by Massachusetts General Hospital. Started May 2009; status: completed.
02
Drugs
creatine
03
Conditions
Huntington's disease (HD)
Beyond the preview
Go deeper on NCT01411150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01411150.